Table 2.

Characteristics of subjects used for analysis.

Characteristic	HC (n = 50)	PD (n = 31)
M/F (n)	23/27	20/11
Age (years)	43.9 ± 10.02	68.1 ± 8.13
Levodopa Equivalent Daily Dose (mg/day)	–	157.81 ± 80.92
Time Since First Diagnosis (years)		5.62 ± 3.46
Hoehn and Yahr (n)	–	H & Y I–2 H & Y II−24 H & Y III−5
MDS-UPDRS III	–	50.55 ± 15.53
Tremor Constancy (MDS-UPDRS 3.18)	–	2.16 ± 1.25
Tremor Amplitude (MDS-UPDRS 3.17)	–	1.42 ± 0.91
Finger Tapping (MDS-UPDRS 3.4)	–	2.65 ± 0.86
Hand Movements (MDS-UPDRS 3.5)	–	2.42 ± 0.98
Pronation Supination (MDS-UPDRS 3.6)	–	2.97 ± 0.86
Hand Bradykinesia (MDS-UPDRS 3.4 + MDS-UPDRS 3.5 + MDS-UPDRS 3.6)	–	8.03 ± 2.4